Nasdaq
BRNS
Barinthus Biotherapeutics plc
- Health Care
- United Kingdom
- Listed 2021
- 1 day
- −0.9%
- 1 month
- −10.2%
- 1 year
- −56.9%
$0.5650 · Mkt cap $23.1M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Barinthus Biotherapeutics plc
$0.5650 · Mkt cap $23.1M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Barinthus Biotherapeutics plc trades under the ticker BRNS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $23.1M. The last closing price was $0.5650, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −56.9%, and −10.2% over the past month. Returns are price returns and exclude dividends.
This page exists because BRNS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.